Recent News

• 09.15.2025 - Paysign, Inc. Announces Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
• 09.15.2025 - Paysign, Inc. Opens 30,000 Square Foot Patient Service Support Center to Meet Growing Demand in Patient Affordability Business
• 09.03.2025 - Paysign, Inc. to Present at the Lake Street Best Ideas Growth BIG9 Conference
• 08.14.2025 - Paysign, Inc. Announces Election of Dan Henry as Chairman of the Board
• 08.08.2025 - Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference
• 08.05.2025 - Paysign, Inc. Reports Second Quarter 2025 Financial Results
• 07.08.2025 - Paysign to Host Second Quarter 2025 Earnings Call
• 06.11.2025 - Paysign Accelerates Growth With Ahead-of-Schedule Transition of 123 Plasma Donation Centers
• 06.06.2025 - Moving Beyond Mitigation: Cracking the Maximizer Code to Protect Patient Affordability

Recent Filings

• 08.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.05.2025 - 8-K Current report
• 08.05.2025 - EX-99.1 EX-99.1
• 08.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.12.2025 - 4 Statement of changes in beneficial ownership of securities